Literature DB >> 2645396

Is HIV unique or merely different?

H M Temin1.   

Abstract

The HIV epidemic is similar to previous human epidemics, and our early responses to the HIV epidemic have likewise been similar. Furthermore, HIV is similar to other single-stranded RNA viruses in its evolution. Like other RNA viruses, HIV has a high mutation rate and thus evolves rapidly. This rapid evolution may make it difficult to develop a successful vaccine against HIV, and perhaps may also limit the usefulness of drugs because of the appearance of resistant mutants. However, most of the variation in HIV nucleotide sequences is neutral, not adaptive. Other viruses in the same retrovirus subfamily as HIV (lentiviruses) are also successful pathogens in animals and are difficult to control without the added problem of the social factors that exist for HIV. These social factors involved in HIV transmission make HIV hard to control by usual public health measures. The prevalence of syphilis and hepatitis B in the United States shows that neither a successful drug treatment nor an effective vaccine is sufficient to stop some infectious diseases when social factors are involved. For these reasons, I conclude that the HIV/AIDs epidemic is different, but not unique.

Entities:  

Mesh:

Year:  1989        PMID: 2645396

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  16 in total

1.  High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus.

Authors:  J C de la Torre; C Giachetti; B L Semler; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

Review 2.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Host-specific driving force in human immunodeficiency virus type 1 evolution in vivo.

Authors:  L Zhang; R S Diaz; D D Ho; J W Mosley; M P Busch; A Mayer
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 4.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

5.  Mutational trends in V3 loop protein sequences observed in different genetic lineages of human immunodeficiency virus type 1.

Authors:  B T Korber; K MacInnes; R F Smith; G Myers
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

6.  Evolution of hypervariable region 1 of hepatitis C virus in primary infection.

Authors:  A Manzin; L Solforosi; E Petrelli; G Macarri; G Tosone; M Piazza; M Clementi
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

7.  Subclonal components of consensus fitness in an RNA virus clone.

Authors:  E A Duarte; I S Novella; S Ledesma; D K Clarke; A Moya; S F Elena; E Domingo; J J Holland
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

8.  Rates of amino acid change in the envelope protein correlate with pathogenicity of primate lentiviruses.

Authors:  E G Shpaer; J I Mullins
Journal:  J Mol Evol       Date:  1993-07       Impact factor: 2.395

9.  Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture.

Authors:  S Sánchez-Palomino; J M Rojas; M A Martínez; E M Fenyö; R Nájera; E Domingo; C López-Galíndez
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

10.  Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response.

Authors:  Cíntia Bittar; Ana Carolina G Jardim; Lilian H T Yamasaki; Artur T L de Queiróz; Claudia M A Carareto; João Renato R Pinho; Isabel Maria V G de Carvalho-Mello; Paula Rahal
Journal:  BMC Infect Dis       Date:  2010-02-23       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.